AIDS and the Drug Companies
Through Medicaid and other programs, most poor people in the United States have access to the new AIDS drug therapies. But in developing countries, their cost—over $10,000 a year—has made their use all but impossible.
Books and Culture
Chapter by chapter, page by page, the reader of this book is engaged with a stimulating thinker who writes journalistically within disjun
This book is at least as interesting because of the process of its creation as it is because of its content.
The coincidence of timing in the publication of these two books, so different in tone, content and style, yet complementary in what they